Principal Financial Group Inc. Decreases Stock Holdings in Chemed Co. (NYSE:CHE)

Principal Financial Group Inc. lessened its stake in shares of Chemed Co. (NYSE:CHE) by 30.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 34,867 shares of the company’s stock after selling 15,547 shares during the quarter. Principal Financial Group Inc. owned about 0.23% of Chemed worth $20,954,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. EntryPoint Capital LLC raised its stake in Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after buying an additional 18 shares during the last quarter. Covestor Ltd lifted its holdings in Chemed by 10.6% in the first quarter. Covestor Ltd now owns 219 shares of the company’s stock valued at $141,000 after acquiring an additional 21 shares during the period. GAMMA Investing LLC lifted its holdings in Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after acquiring an additional 22 shares during the period. Ballentine Partners LLC boosted its position in Chemed by 4.1% in the third quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock worth $394,000 after purchasing an additional 26 shares during the last quarter. Finally, Everpar Advisors LLC grew its stake in shares of Chemed by 4.9% during the 2nd quarter. Everpar Advisors LLC now owns 580 shares of the company’s stock valued at $315,000 after purchasing an additional 27 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada dropped their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.

Insiders Place Their Bets

In other news, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the transaction, the director now directly owns 5,725 shares in the company, valued at $3,271,894.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the transaction, the director now directly owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at $62,117,555.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,144 shares of company stock worth $3,002,419. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Down 0.0 %

Shares of CHE opened at $565.37 on Thursday. The business has a 50-day simple moving average of $580.85 and a two-hundred day simple moving average of $565.47. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62. The stock has a market cap of $8.51 billion, a price-to-earnings ratio of 28.57, a PEG ratio of 2.40 and a beta of 0.46.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. During the same period in the prior year, the company posted $5.32 earnings per share. The company’s revenue was up 7.4% compared to the same quarter last year. On average, equities analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.